48 Ken Fisher GSK Plc Trades
Ken Fisher acquired 18.8 Million GSK Plc shares worth $690 Million. That's 0.29% of their equity portfolio (80th largest holding). The first GSK Plc trade was made in Q1 2013. Since then Ken Fisher bought shares 37 more times and sold shares on ten occasions. The investor's estimated purchase price is $794 Million, resulting in a loss of 13%.
Avg closing price
Price range
Increased shares by 1.4% (+260 Thousand shares)
Q4 2024
Avg closing price
$35.92
Price range
$33.35
-
$40.30
Increased shares by 4.9% (+870 Thousand shares)
Q3 2024
Avg closing price
$40.92
Price range
$38.21
-
$44.26
Increased shares by 13.0% (+2.04 Million shares)
Q2 2024
Avg closing price
$42.07
Price range
$38.50
-
$45.78
Increased shares by 4.2% (+631 Thousand shares)
Q1 2024
Avg closing price
$41.24
Price range
$37.51
-
$43.58
Increased shares by 10.6% (+1.44 Million shares)
Q4 2023
Avg closing price
$35.90
Price range
$34.17
-
$37.56
Sold 1.6% shares (-221 Thousand shares)
Q3 2023
Avg closing price
$35.49
Price range
$33.81
-
$38.07
Increased shares by 4.1% (+547 Thousand shares)
Q2 2023
Avg closing price
$35.87
Price range
$33.60
-
$38.32
Increased shares by 4.4% (+554 Thousand shares)
Q1 2023
Avg closing price
$34.99
Price range
$33.50
-
$36.43
Increased shares by 4.5% (+549 Thousand shares)
Q4 2022
Avg closing price
$33.31
Price range
$30.00
-
$37.92
Sold 37.8% shares (-7.4 Million shares)
Q3 2022
Avg closing price
$36.31
Price range
$28.66
-
$43.91
Increased shares by 3.2% (+601 Thousand shares)
Q2 2022
Avg closing price
$44.17
Price range
$41.24
-
$46.85
Increased shares by 4.1% (+750 Thousand shares)
Q1 2022
Avg closing price
$43.45
Price range
$39.46
-
$46.82
Increased shares by 2.2% (+387 Thousand shares)
Q4 2021
Avg closing price
$41.61
Price range
$38.13
-
$44.44
Increased shares by 1.6% (+282 Thousand shares)
Q3 2021
Avg closing price
$40.18
Price range
$38.05
-
$42.33
Increased shares by 3.1% (+526 Thousand shares)
Q2 2021
Avg closing price
$38.44
Price range
$35.82
-
$40.66
Increased shares by 3.0% (+495 Thousand shares)
Q1 2021
Avg closing price
$36.31
Price range
$33.61
-
$39.24
Increased shares by 1.9% (+300 Thousand shares)
Q4 2020
Avg closing price
$36.75
Price range
$33.42
-
$39.17
Increased shares by 2.2% (+348 Thousand shares)
Q3 2020
Avg closing price
$40.08
Price range
$37.38
-
$42.16
Increased shares by 2.2% (+338 Thousand shares)
Q2 2020
Avg closing price
$41.04
Price range
$37.14
-
$42.74
Increased shares by 0.8% (+127 Thousand shares)
Q1 2020
Avg closing price
$42.67
Price range
$31.85
-
$47.89
News about GSK Plc - ADR and Ken Fisher
7 Stocks Hedge Funds Are Loading Up On
Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact, here ...
Pharmacogenomics Global Market Report 2022
Major players in the pharmacogenomics market are Abbott Laboratories, AstraZeneca plc, Becton Dickinson and Company, Bayer AG, F Hoffmann-La Roche AG, Illumi...